Litcius/Paper detail

Human Pluripotent Stem Cell-Derived Hepatocyte-Like Cells and Organoids for Liver Disease and Therapy

Yang Li, Xia Yang, Richie Plummer, Yoshihito Hayashi, Xiao-Shan Deng, Yunzhong Nie, Hideki Taniguchi

2021International Journal of Molecular Sciences18 citationsDOIOpen Access PDF

Abstract

Liver disease is a global health issue that has caused an economic burden worldwide. Organ transplantation is the only effective therapy for end-stage liver disease; however, it has been hampered by a shortage of donors. Human pluripotent stem cells (hPSCs) have been widely used for studying liver biology and pathology as well as facilitating the development of alternative therapies. hPSCs can differentiate into multiple types of cells, which enables the generation of various models that can be applied to investigate and recapitulate a range of biological activities in vitro. Here, we summarize the recent development of hPSC-derived hepatocytes and their applications in disease modeling, cell therapy, and drug discovery. We also discuss the advantages and limitations of these applications and critical challenges for further development.

Topics & Concepts

Induced pluripotent stem cellOrganoidDiseaseDrug discoveryCell therapyLiver diseaseStem cellDrug developmentEconomic shortageBiologyTransplantationBioinformaticsMedicineComputational biologyCancer researchNeuroscienceCell biologyPharmacologyEmbryonic stem cellDrugPathologyInternal medicinePhilosophyLinguisticsBiochemistryGovernment (linguistics)GenePluripotent Stem Cells ResearchLiver physiology and pathologyCRISPR and Genetic Engineering
Human Pluripotent Stem Cell-Derived Hepatocyte-Like Cells and Organoids for Liver Disease and Therapy | Litcius